Qnomx
Simplified genomics – concise genomics data for labs.

At CGC Genomics, we are transforming cancer genomic data interpretation to optimize therapy selection in oncology. Via our Qnomx platform we are empowering labs to automate the final manual review of genomic profiles, we streamline the genetic testing workflow, enhance efficiency, reduce costs, and increase productivity—ultimately benefiting oncologists and patients by accelerating the time from genomic testing to treatment decisions and improving the quality of those decisions. 

Why Qnomx?

Molecular profiling of tumor DNA is crucial, but the complexity and length of genomic reports—often 20 to 60 pages—create significant challenges for oncologists and lab professionals. These detailed reports often delay critical treatment decisions due to their intricate data. 

Studies indicate that 80% of oncologists find these reports complex, and 50% lack confidence in interpreting them. The manual interpretation process in labs, which takes one to three hours per case, adds to the burden, particularly in rare cancer cases where multiple mutations present conflicting options or resistance markers. Consequently, only 30% of patients who should undergo tumor DNA sequencing actually do, leaving 70% without access to potentially life-saving therapies. For those who do, the process from testing to treatment decisions can take up to 33 days, causing delays in initiating crucial therapies. 

Our Solution

In response to these challenges, CGC Genomics is dedicated to automating the final mile of cancer genomics interpretation. Our AI platform, Qnomx, will be a regulatory-grade, AI-powered tool designed to accelerate genomic insights for laboratories – delivering them 9x faster and 8x more efficiently. It streamlines lab workflows, providing user-friendly access to genomic data, making it as simple to navigate as a conversation, and enhances efficiency, accessibility, and scalability in precision oncology. The platform will offer clear and transparent decision support, engaging users naturally through a conversational interface, and is designed for global deployment across diverse healthcare settings. Additionally, it will continuously integrate the latest research, ensuring every decision is informed by up-to-the-minute data. 

Watch the demo

With Qnomx, CGC Genomics will be setting a new standard in cancer genomics streamlining lab workflows, and advancing the field of precision oncology.